Table 2.
Results of survival analysis for all three cohorts
| Sample size | Outcome (n) | 5-year survival probability (%) | Hazard ratio (95% confidence interval) | Log-rank test | P value | E-value | |
|---|---|---|---|---|---|---|---|
| Obesity | |||||||
| All obesity-related cancers | |||||||
| Reference | 2,555,462 | 45,582 | 97.2 | 1.00 (1.00–1.00) | |||
| Obesity | 2,555,462 | 45,370 | 97.2 | 0.99 (0.98, 1.01) | 3.1 | 0.08 | 1.00 |
| Traditional obesity-related cancers | |||||||
| Reference | 2,555,462 | 37,674 | 97.7 | 1.00 (1.00–1.00) | |||
| Obesity | 2,555,462 | 40,557 | 97.5 | 1.07 (1.05, 1.09) | 89.0 | < 0.01 | 1.34 |
| Type 2 diabetes | |||||||
| All obesity-related cancers | |||||||
| Reference | 290,937 | 8589 | 95.6 | 1.00 (1.00–1.00) | |||
| Type 2 diabetes | 290,937 | 11,207 | 94.5 | 1.27 (1.23, 1.31) | 277.8 | < 0.01 | 1.87 |
| Traditional obesity-related cancers | |||||||
| Reference | 290,937 | 7055 | 96.4 | 1.00 (1.00–1.00) | |||
| Type 2 diabetes | 290,937 | 9775 | 95.2 | 1.35 (1.31, 1.39) | 368.5 | < 0.01 | 2.04 |
| Obesity and type 2 diabetes | |||||||
| All obesity-related cancers | |||||||
| Reference | 609,619 | 16,302 | 96.2 | 1.00 (1.00–1.00) | |||
| Obesity and type 2 diabetes | 609,619 | 21,766 | 95.1 | 1.30 (1.27, 1.32) | 627.8 | < 0.01 | 1.92 |
| Traditional obesity-related cancers | |||||||
| Reference | 609,619 | 13,275 | 96.9 | 1.00 (1.00–1.00) | |||
| Obesity and type 2 diabetes | 609,619 | 20,187 | 95.5 | 1.48 (1.45, 1.51) | 1237.2 | < 0.01 | 2.32 |